Mark J. Holdbrook

V.P., Clinical Affairs, Tarsus Pharmaceuticals, Inc.

Companies

Tarsus Pharmaceuticals, Inc.V.P., Clinical Affairs Oct 15, 2020 to Mar 21, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Tarsus Pharmaceuticals, Inc. TARS3,191 shares²$238.0K at $74.57Mar 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 20, 2023Sold 198 shares at $12.61 of Tarsus Pharmaceuticals, Inc.²
Mar 17, 2023Sold 188 shares at $13.28 of Tarsus Pharmaceuticals, Inc.²
Mar 16, 2023Sold 187 shares at $13.43 of Tarsus Pharmaceuticals, Inc.³
Mar 15, 2023Exercised options 2,653 shares of Tarsus Pharmaceuticals, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTarsus Pharmaceuticals, Inc., V.P., Clinical Affairs
2
SEC EDGARTarsus Pharmaceuticals, Inc. shares after the filing of Mar 20, 2023
3
SEC EDGARForm 4 filed Mar 17, 2023